YPR053C Antibody

What is YPR053C and what biological functions does it serve in Saccharomyces cerevisiae?

YPR053C (Uniprot No. Q6Q5F3) is a protein encoded by the YPR053C gene in Saccharomyces cerevisiae (Baker's yeast, strain ATCC 204508 / S288c). Research suggests this protein may play a role in oxidative stress tolerance pathways in yeast . The protein has been identified in comprehensive genomic studies investigating stress response mechanisms. When designing experiments using the YPR053C antibody, researchers should consider its potential involvement in cellular stress response networks, which may influence experimental conditions and interpretation of results.

What antibody formats are available for YPR053C detection and what are their comparative advantages?

The primary antibody format available for YPR053C is a rabbit-raised polyclonal antibody . This format offers several advantages for research applications:

• Polyclonal nature enables recognition of multiple epitopes on the YPR053C protein

• Antigen affinity purification improves specificity while maintaining sensitivity

• IgG isotype provides compatibility with standard secondary detection systems

What are the recommended storage conditions for maintaining YPR053C antibody activity?

For optimal maintenance of YPR053C antibody activity, the following storage conditions are recommended:

• Store at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles that can degrade antibody structure and function

• The antibody is provided in a storage buffer containing 0.03% Proclin 300 and 50% Glycerol in 0.01M PBS (pH 7.4) , which helps maintain stability

Research has demonstrated that antibody functionality can significantly decrease with improper storage. For long-term research projects, aliquoting the antibody in single-use volumes can minimize freeze-thaw cycles and help maintain consistent experimental results across the research timeline.

How should researchers approach YPR053C antibody validation for studies investigating oxidative stress response?

Comprehensive validation of YPR053C antibody for oxidative stress research requires a multi-pillar approach:

• Genetic validation: Utilize a knockout or knockdown model of YPR053C to confirm antibody specificity. In yeast systems, this could involve testing the antibody against wild-type and YPR053C deletion strains.

• Independent antibody validation: Compare reactivity patterns with another antibody targeting a different epitope of YPR053C, as recommended in antibody validation frameworks . This approach is particularly important since epitope information for commercial antibodies is often not disclosed.

• Stress-specific controls: Include controlled oxidative stress conditions (e.g., hydrogen peroxide treatment) to verify expected changes in expression or localization, as YPR053C has been implicated in oxidative stress response pathways .

• Cross-reactivity assessment: Test the antibody against yeast lysates from different growth phases and stress conditions to ensure consistent target recognition under experimental variables relevant to oxidative stress studies.

The validation approach should be thoroughly documented in publications to enhance reproducibility across research groups.

What strategies can improve detection specificity when using the YPR053C antibody in complex yeast extracts?

Improving detection specificity with YPR053C antibody in complex yeast extracts requires careful optimization:

• Optimized extraction protocols: Use extraction buffers compatible with the preservation of YPR053C epitopes while minimizing non-specific binding. Consider including protease inhibitors and phosphatase inhibitors if phosphorylation state is relevant.

• Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to identify the optimal conditions that minimize background while preserving specific signal.

• Antibody titration: Perform systematic dilution series experiments to identify the minimal antibody concentration that yields specific signal, as higher concentrations can increase non-specific binding.

• Two-dimensional validation: Combine molecular weight confirmation (via Western blot) with localization studies to verify that observed signals match expected characteristics of YPR053C.

• Immunoprecipitation followed by mass spectrometry: For ultimate confirmation of specificity, immunocapture the target followed by peptide sequencing, although interpretation must consider interaction partners .

These approaches collectively enhance confidence in specific detection rather than relying on a single validation method.

How does YPR053C antibody performance compare in detecting native versus recombinant protein forms?

The YPR053C antibody was generated using recombinant YPR053C protein as the immunogen , which may influence its performance differently between native and recombinant detection applications:

• Epitope accessibility: Native proteins may exhibit different folding or post-translational modifications that affect epitope accessibility compared to recombinant forms.

• Expression levels: Recombinant systems typically express proteins at significantly higher levels than native contexts, potentially leading to different signal-to-noise ratios in detection experiments.

• Cross-reactivity profiles: Potential cross-reactivity may manifest differently between native extracts (containing the complete yeast proteome) versus purified recombinant systems.

Researchers should validate the antibody separately for each application using appropriate controls. For native protein detection, validation should include samples with varying expression levels of YPR053C, potentially including knockout or overexpression systems.

What controls are essential when using YPR053C antibody for Western blot analysis of oxidative stress experiments?

When designing Western blot experiments using YPR053C antibody in oxidative stress research, the following controls are essential:

• Positive control: Include a sample containing a known quantity of recombinant YPR053C protein or a yeast strain overexpressing YPR053C.

• Negative control: Include a YPR053C knockout strain lysate to confirm absence of signal.

• Loading control: Use antibodies against constitutively expressed yeast proteins (like actin or tubulin) to normalize for total protein loading.

• Treatment gradient control: Include samples from a gradient of oxidative stress conditions (e.g., different H₂O₂ concentrations) to demonstrate dose-dependent relationships.

• Time-course control: For dynamic processes, include samples from multiple time points to capture the temporal profile of YPR053C response to stress.

• Secondary antibody-only control: Include a lane without primary antibody to identify any non-specific binding from the secondary detection system.

• Isotype control: Include a non-specific rabbit IgG antibody at the same concentration to identify non-specific binding due to the antibody class.

These controls help distinguish specific YPR053C detection from artifacts and establish the biological relevance of observed signals in the context of oxidative stress response.

What are the optimized protocols for immunoprecipitation using YPR053C antibody?

For successful immunoprecipitation using YPR053C antibody, the following optimized protocol is recommended:

• Cell lysis: Harvest yeast cells and prepare lysate in a buffer containing:

  • 50mM HEPES pH 7.5

  • 150mM NaCl

  • 1% Triton X-100

  • 0.1% Sodium deoxycholate

  • 1mM EDTA

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if phosphorylation is relevant)

• Pre-clearing: Incubate lysate with protein A/G beads for 1 hour at 4°C to remove non-specific binding components.

• Antibody binding: Incubate pre-cleared lysate with 2-5μg YPR053C antibody per 1mg of total protein overnight at 4°C with gentle rotation.

• Immunocapture: Add protein A/G beads and incubate for 2-4 hours at 4°C.

• Washing: Perform stringent washing steps (at least 4-5 washes) with decreasing salt concentrations to remove non-specific interactions while preserving specific binding.

• Elution: Elute with either gentle acid elution or by boiling in SDS sample buffer, depending on downstream applications.

• Verification: Confirm successful immunoprecipitation by Western blot analysis using a portion of the eluted material.

For complex interaction studies, consider crosslinking the antibody to beads to avoid antibody contamination in the eluted material, which is particularly important for mass spectrometry analysis of binding partners.

How should researchers design experiments to investigate YPR053C's role in oxidative stress tolerance?

To effectively investigate YPR053C's role in oxidative stress tolerance, researchers should implement the following experimental design approach:

• Genetic manipulation strategy:

  • Generate YPR053C knockout strain

  • Create YPR053C overexpression strain

  • Develop strains with mutated versions of YPR053C to identify functional domains

• Stress exposure protocol:

  • Subject strains to various oxidative stressors (H₂O₂, paraquat, menadione)

  • Establish dose-response relationships for each strain

  • Implement time-course experiments to capture temporal dynamics

• Phenotypic assays:

  • Growth curve analysis under stress conditions

  • Viability assessment (colony counting or flow cytometry with viability dyes)

  • ROS measurement using fluorescent probes

  • Measurement of oxidative damage markers (protein carbonylation, lipid peroxidation)

• Molecular analysis:

  • Use YPR053C antibody to track protein expression and localization changes

  • Combine with fluorescent tagging for live-cell imaging when appropriate

  • Implement quantitative Western blotting to measure expression level changes

  • Use the antibody for co-immunoprecipitation to identify stress-dependent interaction partners

• Transcriptional analysis:

  • Perform qPCR to measure YPR053C transcript levels under stress

  • Consider RNA-seq for genome-wide effects of YPR053C manipulation

This comprehensive approach enables both phenotypic characterization and mechanistic insight into YPR053C's function in stress response pathways.

What are the minimum validation requirements for YPR053C antibody before publication-quality research?

Based on current consensus and reproducibility standards , the minimum validation requirements for YPR053C antibody before use in publication-quality research include:

• Genetic validation: Demonstration of signal absence/reduction in YPR053C knockout/knockdown yeast strains.

• Molecular weight verification: Confirmation that the detected band matches the predicted molecular weight of YPR053C.

• Application-specific validation: Separate validation for each experimental method (Western blot, immunoprecipitation, immunocytochemistry).

• Lot-to-lot consistency check: Verification that new antibody lots perform similarly to previously validated lots.

• Signal specificity demonstration: Evidence that the signal changes as expected with experimental manipulations that should affect YPR053C levels.

• Independent method correlation: Correlation of antibody-based detection with an orthogonal method (e.g., mass spectrometry or RNA expression).

These validation steps should be thoroughly documented in the methods section of publications, with key validation data included in supplementary materials to enhance reproducibility across research groups.

How can researchers effectively characterize the epitope specificity of YPR053C antibody?

Effective characterization of YPR053C antibody epitope specificity can be achieved through:

• Epitope mapping techniques:

  • Peptide array analysis using overlapping peptides spanning the YPR053C sequence

  • Alanine scanning mutagenesis to identify critical residues for antibody recognition

  • Hydrogen-deuterium exchange mass spectrometry to identify protected regions upon antibody binding

• Competitive binding assays:

  • Pre-incubation of antibody with purified recombinant fragments of YPR053C

  • Observation of signal reduction in Western blot or immunoprecipitation to identify binding regions

• Structural analysis:

  • If protein structure is available, in silico prediction of surface-exposed regions

  • Correlation of these predictions with experimental epitope mapping data

• Cross-reactivity assessment:

  • Testing against closely related yeast proteins to determine specificity boundaries

  • Analysis against mutated versions of YPR053C to identify critical epitope components

Complete epitope characterization enhances experimental design by informing which domains of YPR053C remain accessible under various experimental conditions and which post-translational modifications might interfere with antibody binding.

What metrics should be used to assess YPR053C antibody performance across different experimental methods?

To comprehensively evaluate YPR053C antibody performance across experimental methods, researchers should assess:

• For Western blot applications:

  • Signal-to-noise ratio under standardized conditions

  • Dynamic range of detection (linear relationship between protein amount and signal)

  • Limit of detection (minimum amount of protein reliably detected)

  • Reproducibility coefficient (variation across technical replicates)

• For immunoprecipitation efficiency:

  • Percent recovery of target protein from input material

  • Specificity ratio (target protein versus non-specific proteins)

  • Reproducibility of protein complex identification

• For immunofluorescence applications:

  • Signal intensity compared to background

  • Subcellular localization specificity

  • Consistency with expected distribution patterns

  • Correlation with fluorescently tagged YPR053C distribution

• For ELISA applications:

  • Standard curve linearity

  • Coefficient of variation across technical replicates

  • Lower limit of quantification

  • Spike-recovery consistency

These metrics should be systematically documented and reported in publications to enable other researchers to evaluate the reliability of results and appropriately design their own experiments with this antibody.

How should researchers address inconsistent results when using YPR053C antibody across different experimental conditions?

When facing inconsistent results with YPR053C antibody across experimental conditions, implement this systematic troubleshooting approach:

• Antibody integrity assessment:

  • Verify storage conditions have been maintained

  • Check for signs of antibody degradation (precipitation, cloudy appearance)

  • Consider running a small aliquot on SDS-PAGE to check for antibody fragmentation

• Protocol consistency analysis:

  • Document all protocol variables (buffers, incubation times, temperatures)

  • Standardize key reagents across experiments

  • Implement protocol checklists to ensure methodological consistency

• Sample preparation variables:

  • Evaluate whether different growth conditions affect YPR053C epitope accessibility

  • Consider whether post-translational modifications under different conditions affect antibody binding

  • Standardize cell lysis and protein extraction methods

• Experimental design revision:

  • Include internal controls in each experiment to normalize results

  • Run samples from previous successful experiments alongside new conditions

  • Consider using technical replicates to distinguish biological variation from technical issues

• Antibody titration optimization:

  • Re-optimize antibody concentration for each specific condition

  • Test different incubation times and temperatures

When publishing results, transparently report optimization procedures and acknowledge limitations in antibody performance across specific conditions.

What are the most common artifacts and false positives when working with YPR053C antibody, and how can they be distinguished from genuine signals?

Common artifacts and false positives when working with YPR053C antibody, and methods to distinguish them from genuine signals include:

• Non-specific bands in Western blot:

  • Distinguish by comparing migration patterns to predicted molecular weight

  • Verify with YPR053C knockout controls

  • Confirm specificity with peptide competition assays

• Background staining in immunofluorescence:

  • Distinguish from specific signal using YPR053C knockout controls

  • Compare with secondary antibody-only controls to identify non-specific binding

  • Verify localization pattern with orthogonal methods (e.g., GFP-tagged YPR053C)

• Co-precipitating proteins in immunoprecipitation:

  • Distinguish true interactions from non-specific binding using stringent washing

  • Confirm with reverse immunoprecipitation approaches

  • Validate key interactions with independent methods like proximity ligation assay

• Cross-reactivity with related proteins:

  • Identify potential cross-reactive proteins through sequence similarity analysis

  • Test antibody against recombinant versions of related proteins

  • Use mass spectrometry to identify precisely which proteins are being detected

• Stress-induced artifacts:

  • Control for stress-induced proteolysis that may generate fragments detected by the antibody

  • Distinguish from genuine stress response through time-course analysis

  • Verify with orthogonal stress markers

Documentation of these potential artifacts and control experiments should be included in publications to enhance methodology transparency and reproducibility.

How can researchers integrate YPR053C antibody data with other experimental approaches to build a comprehensive understanding of its role in stress response?

Effective integration of YPR053C antibody data with complementary approaches requires:

• Multi-level analytical framework:

  • Correlate protein detection (antibody-based) with transcript levels (RNA-seq or qPCR)

  • Connect protein abundance with functional assays (growth, survival, stress resistance)

  • Link protein interactions (co-immunoprecipitation) with genetic interaction data

• Temporal integration strategy:

  • Map the sequence of molecular events following stress induction

  • Determine where YPR053C activation/regulation fits in the stress response timeline

  • Correlate YPR053C dynamics with downstream effector activation

• Spatial analysis coordination:

  • Combine subcellular localization data from immunofluorescence with fractionation studies

  • Correlate YPR053C localization changes with organelle-specific stress markers

  • Link localization dynamics to interaction partner profiles

• Quantitative correlation approaches:

  • Perform rigorous statistical analysis across experimental modalities

  • Develop predictive models based on YPR053C levels/modifications and phenotypic outcomes

  • Implement machine learning approaches to identify patterns across diverse datasets

• Pathway integration:

  • Map YPR053C into known stress response pathways using protein interaction data

  • Identify regulatory relationships through genetic epistasis experiments

  • Construct network models incorporating YPR053C antibody-derived data with genetic and functional results